San­doz un­veils glob­al ac­tion plan to im­prove ac­cess to biosim­i­lars

3 years ago
Pharma
FDA+

Ex­clu­sive: mR­NA CD­MO Ver­nal Bio­sciences se­cures $20M to con­tin­ue its build­out

3 years ago
Financing
Manufacturing

France looks to boost its do­mes­tic sup­ply of drugs

3 years ago
Manufacturing

Man­u­fac­tur­ing roundup: Fer­ring looks to scale up gene ther­a­py; Eu­roAPI looks to boost pro­duc­tion of pain med­i­cine

3 years ago
Manufacturing

Tis­sue re­gen­er­a­tion biotech rais­es $26M Se­ries A to push to­ward clin­i­cal tri­als

3 years ago
Financing

Syn­cona takes write-down on Swan­Bio as biotech halves work­force to fo­cus on one gene ther­a­py

3 years ago
Financing
Startups

Corvus touts ear­ly da­ta on T cell lym­phoma drug, makes PhI­II plans

3 years ago
R&D

Mer­sana slapped with par­tial FDA hold af­ter five pa­tient deaths in ovar­i­an can­cer stud­ies

3 years ago
R&D
FDA+

To sN­DA or NDA? Aldeyra clears a sec­ond PhI­II for sea­son­al al­ler­gy eye drop

3 years ago
R&D

'Mod­er­na will be a rare dis­ease com­pa­ny,' CEO says, as mR­NA com­pa­ny plots ex­pan­sion in ge­net­ic dis­eases and eyes ...

3 years ago
R&D
Pharma

Astel­las shells out $35M up­front to Cull­gen in pro­tein de­grad­er de­vel­op­ment deal

3 years ago
Deals

Pfiz­er re­files Seagen ac­qui­si­tion pa­per­work, deal still ex­pect­ed to close with­in the year

3 years ago
R&D

Verve snags $60M from Lil­ly to tack­le Lp(a) with one-time gene edit­ing

3 years ago
Deals
Pharma

Three chil­dren with leukemia treat­ed with first base-edit­ed cell ther­a­py; one died from in­fec­tion

3 years ago
R&D

Mer­ck gets a patent win for mus­cle re­lax­ant re­ver­sal drug

3 years ago
Pharma
Law

To restart com­mon can­cer drug pro­duc­tion short­ly, FDA work­ing close­ly with Ac­cord

3 years ago
Pharma
FDA+

Pep­Gen de­lays PhI study on my­oton­ic dy­s­tro­phy as it awaits more in­fo on clin­i­cal hold

3 years ago
Pharma

Pfiz­er ad­ver­tis­ing com­mu­ni­ca­tions to Meta sub­poe­naed by state of Texas as part of pri­va­cy law­suit — re­port

3 years ago
Pharma
Marketing

Astel­las CEO Nao­ki Oka­mu­ra says part­ner­ships 'crit­i­cal' to growth plans

3 years ago
People
Pharma

Pfiz­er says peni­cillin in­jec­tion may soon be in short sup­ply

3 years ago
Pharma
Manufacturing

Am­gen taps Mod­er­na vet Paul Bur­ton as new CMO

3 years ago
People
Pharma

IRA side ef­fect: Phar­ma com­pa­nies will in­creas­ing­ly skip Medicare al­to­geth­er, Lil­ly CEO says

3 years ago
Pharma
Law

Vi­a­tris pe­ti­tions FDA over would-be EpiPen com­peti­tor, claim­ing more da­ta nec­es­sary

3 years ago
FDA+

LA­VA Ther­a­peu­tics winds down bis­pe­cif­ic tri­al; Blue Wa­ter buys six mar­ket­ed drugs for $8.5M

3 years ago
News Briefing
First page Previous page 326327328329330331332 Next page Last page
A service from the Financial Times